Free tool
FAERS Monitor: Sodium Chloride 0.9% In Plastic Container
Last checked: Nov 19, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 016366 or its brand name (Sodium Chloride 0.9% In Plastic Container, Sodium Chloride). Reports on generic versions are filed under their own applications.
Reports
75,824
Serious
60,821
80% of reports
Hospitalization
34,337
Death reported
6,415
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- myelosuppression5,526
- nausea5,445
- dyspnoea4,775
- off label use4,708
- headache4,416
- pyrexia4,328
- fatigue4,226
- vomiting3,888
- diarrhoea3,774
- pneumonia3,446
- pain2,969
- white blood cell count decreased2,947
- cough2,652
- drug ineffective2,491
- dizziness2,482
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 118 |
| 2005 | 182 |
| 2006 | 272 |
| 2007 | 248 |
| 2008 | 266 |
| 2009 | 413 |
| 2010 | 399 |
| 2011 | 585 |
| 2012 | 852 |
| 2013 | 690 |
| 2014 | 1,147 |
| 2015 | 2,148 |
| 2016 | 3,096 |
| 2017 | 2,485 |
| 2018 | 3,596 |
| 2019 | 5,072 |
| 2020 | 6,387 |
| 2021 | 5,734 |
| 2022 | 7,390 |
| 2023 | 7,783 |
| 2024 | 9,511 |
| 2025 | 9,912 |
| 2026 | 7,535 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,978,335 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| myelosuppressionSignal | 5,526 | 50.1 | 48.7 | 225,412 |
| white blood cell count decreasedSignal | 2,947 | 7.7 | 7.5 | 16,862 |
| pyrexiaSignal | 4,328 | 3.5 | 3.4 | 7,761 |
| pneumoniaSignal | 3,446 | 3.0 | 2.9 | 4,533 |
| coughSignal | 2,652 | 2.6 | 2.5 | 2,708 |
| dyspnoeaSignal | 4,775 | 2.4 | 2.3 | 3,777 |
| vomitingSignal | 3,888 | 2.3 | 2.2 | 2,912 |
| headache | 4,416 | 2.0 | 1.9 | 2,126 |
| nausea | 5,445 | 1.9 | 1.9 | 2,454 |
| diarrhoea | 3,774 | 1.6 | 1.6 | 931 |
| fatigue | 4,226 | 1.5 | 1.5 | 747 |
| off label use | 4,708 | 1.5 | 1.5 | 798 |
| dizziness | 2,482 | 1.4 | 1.3 | 267 |
| pain | 2,969 | 1.3 | 1.3 | 265 |
| drug ineffective | 2,491 | 0.5 | 0.5 | 1,151 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.